State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions

被引:0
|
作者
Bormann, Nicholas L. [1 ]
Weber, Andrea N. [2 ,3 ]
Oesterle, Tyler S. [1 ]
Miskle, Benjamin [2 ,4 ]
Lynch, Alison C. [2 ,5 ]
Arndt, Stephan [2 ,6 ]
机构
[1] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA
[2] Univ Iowa, Dept Psychiat, Iowa City, IA USA
[3] Univ Iowa, Dept Internal Med, Iowa City, IA USA
[4] Univ Iowa, Dept Pharm, Iowa City, IA USA
[5] Univ Iowa, Dept Family Med, Iowa City, IA USA
[6] Univ Iowa, Dept Biostat, Iowa City, IA USA
来源
AMERICAN JOURNAL ON ADDICTIONS | 2025年 / 34卷 / 01期
关键词
METHADONE CONTINUATION; FORCED WITHDRAWAL; MEDICATIONS; INCARCERATION; ADDICTION; ADULTS; PRISON; JAIL;
D O I
10.1111/ajad.13636
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and ObjectivesCriminal-legal (CL) referrals to addiction treatment have historically had low utilization of medications for opioid use disorder (MOUD). While state differences have been reported, an in-depth longitudinal analysis of state-by-state differences is lacking.MethodsThe Substance Abuse and Mental Health Services Administration Treatment Episode Dataset-Admissions 2000-2020 provided data for individuals entering their initial treatment with an opioid as their primary substance. Outcome was planned use of MOUD, assessing odds ratio (OR) of CL referrals relative to non-CL referrals cumulatively over the 21-year period and as incremental change (change in relative disparity) using effect sizes, stratified by each state.Results2,187,447 cases met the criteria. Planned MOUD occurred in 37.7% of non-CL clients versus 6.5% of CL clients (OR = 0.11, 95% confidence interval = 0.11-0.12). For all clients, planned MOUD increased from 2000 (33.9%) to 2020 (44.8%). This increase was blunted within CL clients, increasing from 2000 (6.4%) to 2020 (13.3%). Rhode Island saw the greatest improvements in equity.Discussion and ConclusionsWhile rates of planned MOUD increased over the 21 years, a significant disparity persisted among CL clients in most states. As opioid use disorders and opioid-related overdoses are more prevalent among those involved with the CL system, improving this has high impact.Scientific SignificanceProvides the most comprehensive analysis of state-by-state inequities in MOUD access for CL relative to non-CL referrals over a 21-year period through use of a national data set. Positive outliers are used as case examples for others to follow in pursuit of more equitable care.
引用
收藏
页码:60 / 68
页数:9
相关论文
共 50 条
  • [1] Inequities in the treatment of opioid use disorder: A scoping review
    Magee, Trevor
    Peters, Caleb
    Jacobsen, Samuel M.
    Nees, Danya
    Dunford, Bryan
    Ford, Alicia Ito
    Vassar, Matt
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 152
  • [2] Dosing Inequities in Opioid Use Disorder Treatment Trials
    Schiff, Davida M.
    Nidey, Nichole
    Tiako, Max Jordan Nguemeni
    JAMA NETWORK OPEN, 2024, 7 (10)
  • [3] Evidence of telescoping in females across two decades of US treatment admissions for injection drug use: 2000-2020
    Bormann, Nicholas L.
    Miskle, Benjamin
    Holdefer, Paul
    Arndt, Stephan
    Lynch, Alison C.
    Weber, Andrea N.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 9
  • [4] Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the US, 2015-2018
    Stahler, Gerald J.
    Mennis, Jeremy
    Stein, L. A. R.
    Belenko, Steven
    Rohsenow, Damaris J.
    Grunwald, Heidi E.
    Brinkley-Rubinstein, Lauren
    Martin, Rosemarie A.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 236
  • [5] State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015
    Mantha, Shivani
    Mauro, Pia M.
    Mauro, Christine M.
    Martins, Silvia S.
    DRUG AND ALCOHOL DEPENDENCE, 2020, 206
  • [6] DISPARITIES IN TREATMENT ADMISSIONS FOR OPIOID USE DISORDER IN CINCINNATI BY RACE
    Mercado, M.
    Mallow, P.
    VALUE IN HEALTH, 2020, 23 : S208 - S209
  • [7] Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries
    Harris, Samantha J.
    Abraham, Amanda J.
    Andrews, Christina M.
    Yarbrough, Courtney R.
    HEALTH AFFAIRS, 2020, 39 (02) : 233 - 237
  • [8] State level variation in substance use treatment admissions among criminal legal-referred individuals
    Shearer, Riley D.
    Winkelman, Tyler N. A.
    Khatri, Utsha G.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 240
  • [9] Opioid Use Disorder Treatment Outcomes in US Veterans
    Griffith, Patricia S.
    Brown, Lana M.
    Lensing, Shelly Y.
    Nahata, Ravi
    Padala, Prasad R.
    Snow, Lisa
    Milholland, Katherine
    Mullins, Melinda
    JOURNAL OF ADDICTIONS NURSING, 2022, 33 (04) : 322 - 325
  • [10] Racial and ethnic inequities in substance use treatment among women with opioid use disorder
    Scheidell, Joy D.
    Pitre, Maya
    Andraka-Christou, Barbara
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2024, 50 (01): : 106 - 116